pharmacie et médicaments – Essais cliniques internationaux

This written question concerns international clinical trials for pharmaceuticals and medicines. It seeks clarification on the regulatory framework and procedures governing these trials within the European Union. The question aims to understand the implications for patients, researchers, and the pharmaceutical industry, potentially impacting drug development and access to innovative treatments across member states.